MANZI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 876
EU - Europa 573
AS - Asia 241
AF - Africa 16
SA - Sud America 4
OC - Oceania 1
Totale 1.711
Nazione #
US - Stati Uniti d'America 862
IT - Italia 351
SG - Singapore 161
SE - Svezia 68
IN - India 33
DE - Germania 29
FI - Finlandia 21
CN - Cina 19
FR - Francia 19
NL - Olanda 17
GB - Regno Unito 16
TG - Togo 15
CA - Canada 14
RU - Federazione Russa 10
BG - Bulgaria 9
ID - Indonesia 9
RO - Romania 7
IR - Iran 6
PH - Filippine 5
PL - Polonia 5
AR - Argentina 4
UA - Ucraina 4
BE - Belgio 3
AT - Austria 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
IE - Irlanda 2
JP - Giappone 2
LT - Lituania 2
PT - Portogallo 2
TW - Taiwan 2
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.711
Città #
Rome 139
Singapore 129
Fairfield 108
Chandler 78
Ashburn 62
Woodbridge 47
Seattle 44
Cambridge 41
Santa Clara 39
Houston 34
Wilmington 32
Milan 25
Princeton 25
San Diego 21
Dearborn 18
Lomé 15
San Paolo di Civitate 15
Groningen 13
Helsinki 13
Lawrence 13
New York 12
Boston 11
Millbury 11
Beijing 9
Jakarta 9
Sofia 9
Toronto 9
Andover 7
Naples 7
Paris 7
Fremont 6
Norwalk 6
Plano 6
Boardman 5
London 5
Rende 5
Bonate Sotto 4
Carrara 4
Formia 4
Gdansk 4
Lappeenranta 4
Leawood 4
Moscow 4
Ottawa 4
Redwood City 4
Ann Arbor 3
Bari 3
Blackburn 3
Bologna 3
Brussels 3
Chennevières-sur-marne 3
Falkenstein 3
Federal 3
Florence 3
Lavis 3
Southend 3
Taguig 3
Zanjan 3
Bergamo 2
Bremen 2
Cardito 2
Catania 2
Cremona 2
Des Moines 2
Dublin 2
Foligno 2
Fort Worth 2
Hyderabad 2
Lecce 2
Lisbon 2
Mannheim 2
Meppel 2
Nanjing 2
New Taipei 2
Palermo 2
Pamplona 2
Romainville 2
Saint-Fons 2
San Mateo 2
Tarlac City 2
Tottori-shi 2
Varese 2
Vrilissia 2
West Jordan 2
Wolfenbüttel 2
Agropoli 1
Alatri 1
Albignasego 1
Almaty 1
Ankara 1
Arnsberg 1
Atlanta 1
Auckland 1
Beauharnois 1
Bitonto 1
Bovisio Masciago 1
Buenos Aires 1
Buscate 1
Civitavecchia 1
Curtarolo 1
Totale 1.179
Nome #
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 121
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 112
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 106
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 98
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 95
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 93
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 79
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 75
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 61
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 59
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 58
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 57
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up 56
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 55
The importance of right ventricular function in patients with pulmonary arterial hypertension 54
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension 54
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis 52
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension 49
Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china 39
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era. is risk of disease progression around the corner 38
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension 36
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension 33
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution). proposal of a study protocol aimed to realize a validated risk score for early diagnosis 33
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 32
Gaps of evidence in pulmonary arterial hypertension 28
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension 27
Comment on topyła-putowska et al. echocardiography in pulmonary arterial hypertension. comprehensive evaluation and technical considerations. j. clin. med. 2021, 10, 3229 25
Biobanks: the unmet need in heart failure management 24
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing 24
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy. results from a single center experience 24
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 21
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension 21
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension. a systematic review and network meta-analysis 19
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension. determinants and clinical impact 18
Right ventricular/pulmonary artery coupling in patients with heart failure with preserved ejection fraction. a clue for pulmonary hypertension 16
Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients 14
Phenotypes of idiopathic pulmonary arterial hypertension 12
Prognostic assessment of hlm score in heart failure due to ischemic heart disease. a pilot study 10
SGLT2i effect on atrial fibrillation. a network meta-analysis of randomized controlled trials 6
Totale 1.834
Categoria #
all - tutte 8.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020103 0 0 0 0 0 0 29 24 22 13 4 11
2020/2021204 11 15 4 3 3 8 3 12 42 70 18 15
2021/2022340 24 16 3 20 17 16 4 24 45 31 81 59
2022/2023394 50 73 35 37 43 48 4 20 51 5 19 9
2023/2024279 18 37 35 15 28 22 14 22 5 28 30 25
2024/2025325 20 89 59 39 57 61 0 0 0 0 0 0
Totale 1.834